treatment-emergent adverse events 分级treatment-emergent adverse events 分级 treatment-emergent adverse events 分级的中文意思为:治疗突发不良事件分级©2022 Baidu |由 百度智能云 提供计算服务 | 使用百度前必读 | 文库协议 | 网站地图 | 百度营销
1.治疗后出现的不良事件 治疗后出现的不良事件（Treatment Emergent Adverse Events）指从开始用药到停药期间发生的不良事件。
待解决 悬赏分:1 - 离问题结束还有 treatment related adverse events data问题补充:匿名 2013-05-23 12:21:38 null 匿名 2013-05-23 12:23:18 治疗相关的不良事件的数据。 匿名 2013-05-23 12:24:58 治疗相关有害事件数据 匿名 2013-05-23 12:26:38 治疗相关的不良事件数据 匿名 2013-...
[translate] a水平不中啊 Level not [translate] aThe most common treatment-related adverse events were rash, diarrhea and pruritus. 最共同的与治疗相关的有害事件是轻率,腹泻和瘙痒。 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 葡萄牙语翻译 意大利语翻译...
a祝愿你和朋友玩的愉快 Wishes happiness which you and the friend play[translate] apieas give me a havnd pieas给我一havnd[translate] aThe most commonly reported treatment-related adverse events were epistaxis 通常报告的与治疗相关的有害事件是流鼻血[translate]...
ObjectiveTo examine the impact of schizophrenia, its treatment and treatment-related adverse events related to antipsychotics, on quality of life from the ... A Briggs,D Wild,M Lees,... - 《Health & Quality of Life Outcomes》 被引量: 95发表: 2008年 Outcomes of ipilimumab treatment-related ...
Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/ refractory acute lymphoblastic leukemia... W Sun,E Orgel,J Malvar,... - 《Pediatric Blood & Cancer》 被引量: 4发表: 2016年 Treatment-related adverse events associated with ...
This review aims to provide a current overview of common adverse events associated with atypical agents with a particular emphasis on adverse events that frequently lead to treatment discontinuation (e.g., changes in weight, metabolism, extrapyramidal side effects, neuroendocrine changes, blood ...
Treatment-Related Adverse Events and Outcome in a Clinical Trial of Fluoxetine for Major Depressive Disorder Treatment-related adverse events (TRAEs), particularly those that occur early on, may increase the likelihood for premature discontinuation of antidepressa... George,I.,Papakostas,... - 《Ann...
Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients With Myelofibrosis Ruxolitinib (INCB018424) is a JAK1 and JAK2 inhibitor recently evaluated for the treatment of myelofibrosis (MF) in early- and advanced-phase clinical tria... A Tefferi,A Pardanani - 《Mayo Clinic ...